SEC Form 3 · accession 0001209191-19-008778
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Krueger
Officer — General Counsel
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 8:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 14,999 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $17.74 | holding | — | — | — | — | Oct 10, 2024 | Common Stock | 35,608 | — | D |
| Stock Option (right to buy)F2 | $9.15 | holding | — | — | — | — | Apr 17, 2025 | Common Stock | 6,286 | — | D |
| Stock Option (right to buy)F3 | $14.00 | holding | — | — | — | — | May 6, 2025 | Common Stock | 8,800 | — | D |
| Stock Option (right to buy)F4 | $10.24 | holding | — | — | — | — | Oct 1, 2025 | Common Stock | 17,000 | — | D |
| Stock Option (right to buy)F5 | $6.14 | holding | — | — | — | — | Jan 27, 2026 | Common Stock | 20,000 | — | D |
| Stock Option (right to buy)F6 | $3.06 | holding | — | — | — | — | Sep 13, 2026 | Common Stock | 36,500 | — | D |
| Stock Option (right to buy)F7 | $3.30 | holding | — | — | — | — | Feb 7, 2027 | Common Stock | 35,000 | — | D |
| Stock Option (right to buy)F8 | $3.30 | holding | — | — | — | — | Feb 6, 2028 | Common Stock | 50,000 | — | D |
| Stock Option (right to buy)F9 | $0.85 | holding | — | — | — | — | May 16, 2028 | Common Stock | 50,000 | — | D |
| Restricted Stock UnitsF11,F10 | — | holding | — | — | — | — | — | Common Stock | 25,000 | — | D |
Explanation of responses
- F1The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning November 7, 2014. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F10The restricted stock units (RSUs) are scheduled to vest in two equal annual installments beginning May 16, 2019, such that this grant will be fully vest on May 16, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- F11Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning May 17, 2015. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F3The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning June 6, 2015. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F4The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning November 1, 2015. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F5The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning February 1, 2016. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F6The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning October 13, 2016. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F7The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning March 7, 2017. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F8The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning March 6, 2018. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
- F9The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning June 16, 2018. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.